Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan
Clinical trial NCT01424319 · COMPLETED
Trial details
- NCT number
- NCT01424319
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-07-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.